
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Intractable crying in infants and young children can be a language all of its own-capable of communicating underlying disease. Here's what pediatricians need to know to avoid getting lost in translation.
Please click here to go directly to the CME site. (Registration required)






